April 19, 2024 Experience Barratt Developments £2.52 billion all-share offer for Redrow We are advising UBS as financial adviser and sponsor to Barratt Developments on the transaction
April 1, 2024 Experience Nuvei $6.3 billion going-private acquisition We are advising Nuvei on the transaction
March 25, 2024 Experience Galderma Group CHF2.3 billion ($2.6 billion) IPO We advised Galderma on its IPO
March 22, 2024 Experience JPMorgan Chase €2 billion notes offering We advised JPMorgan Chase on the euro notes offering
March 21, 2024 Experience Smith+Nephew $1 billion notes offering We advised the issuer on the SEC-registered offering
March 14, 2024 Experience BBVA $2 billion senior notes offering We advised BBVA on its offering of senior preferred fixed-rate notes and senior non-preferred fixed-to-fixed-rate notes
March 14, 2024 Experience Banco Santander $4 billion notes offering We advised Banco Santander on the notes due 2028, 2030 and 2034
March 12, 2024 Experience Nestlé Capital $2.5 billion notes offering The investment-grade notes are due 2029, 2031, 2034 and 2054
March 8, 2024 Experience Roche Holdings $3.875 billion notes offering We advised Roche on the Rule 144A / Regulation S offering comprising four tranches of notes